Donald S Karanewsky - JoVE Visualize

Showing results (1-10 of 41) with videos related to

Pageof 5

Sort By:

Trends in Pharmacological Sciences|August 3, 2011

The sweet taste of true synergy: positive allosteric modulation of the human sweet taste receptorGuy Servant, Catherine Tachdjian, Xiaodong Li, et al.

Toxicology Reports|October 1, 2017

Toxicological evaluation of a novel cooling compound: 2-(4-methylphenoxy)-<i>N</i>-(1<i>H</i>-pyrazol-3-yl)-<i>N</i>-(2-thienylmethyl)acetamideDonald S Karanewsky, Amy J Arthur, Hanghui Liu, et al.

Toxicology Reports|September 30, 2017

Toxicological evaluation and metabolism of two <i>N</i>-alkyl benzamide umami flavour compounds: <i>N</i>-(heptan-4-yl)benzo[d][1,3]dioxole-5-carboxamide and (<i>R</i>)-<i>N</i>-(1-methoxy-4-methylpentan-2-yl)-3,4-dimethylbenzamideDonald S Karanewsky, Amy J Arthur, Hanghui Liu, et al.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 2, 2014

Toxicological evaluation of two flavors with modifying properties: 3-((4-amino-2,2-dioxido-1H-benzo[c][1,2,6]thiadiazin-5-yl)oxy)-2,2-dimethyl-N-propylpropanamide and (S)-1-(3-(((4-amino-2,2-dioxido-1H-benzo[c][1,2,6]thiadiazin-5-yl)oxy)methyl)piperidin-1-yl)-3-methylbutan-1-oneAmy J Arthur, Donald S Karanewsky, Mike Luksic, et al.

Toxicology Reports|October 1, 2017

Toxicological evaluation of the flavour ingredient 4-amino-5-(3-(isopropylamino)-2,2-dimethyl-3-oxopropoxy)-2-methylquinoline-3-carboxylic acidAmy J Arthur, Donald S Karanewsky, Hanghui Liu, et al.

Toxicology Reports|September 30, 2017

Toxicological evaluation of two novel bitter modifying flavour compounds: 3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1<i>H</i>-pyrazol-4-yl)-1-(3-hydroxybenzyl)imidazolidine-2,4-dione and 3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1<i>H</i>-pyrazol-4-yl)-1-(3-hydroxybenzyl)-5,5-dimethylimidazolidine-2,4-dioneDonald S Karanewsky, Amy J Arthur, Hanghui Liu, et al.

Toxicology Reports|September 30, 2017

Toxicological evaluation of a novel umami flavour compound: 2-(((3-(2,3-Dimethoxyphenyl)-1<i>H</i>-1,2,4-triazol-5-yl)thio)methyl)pyridineDonald S Karanewsky, Amy J Arthur, Hanghui Liu, et al.

Bioorganic & Medicinal Chemistry Letters|February 17, 2005

Structure-activity relationships and sub-type selectivity in an oxabicyclic estrogen receptor alpha/beta agonist scaffoldLawrence G Hamann, J Hoyt Meyer, Daniel A Ruppar, et al.

Toxicology Reports|September 30, 2017

Toxicological evaluation of the flavour ingredient <i>N</i>-(1-((4-amino-2,2-dioxido-1<i>H</i>-benzo[<i>c</i>][1,2,6]thiadiazin-5-yl)oxy)-2-methylpropan-2-yl)-2,6-dimethylisonicotinamide (S2218)Donald S Karanewsky, Guy Servant, Hanghui Liu, et al.

Ejhaem|July 18, 2022

The ClpP activator ONC-212 (TR-31) inhibits BCL2 and B-cell receptor signaling in CLLNarjis Fatima, Yandong Shen, Kyle Crassini, et al.

Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:

Pageof 5

Trends in Pharmacological Sciences|August 3, 2011

The sweet taste of true synergy: positive allosteric modulation of the human sweet taste receptorGuy Servant, Catherine Tachdjian, Xiaodong Li, et al.

Toxicology Reports|October 1, 2017

Toxicological evaluation of a novel cooling compound: 2-(4-methylphenoxy)-<i>N</i>-(1<i>H</i>-pyrazol-3-yl)-<i>N</i>-(2-thienylmethyl)acetamideDonald S Karanewsky, Amy J Arthur, Hanghui Liu, et al.

Toxicology Reports|September 30, 2017

Toxicological evaluation and metabolism of two <i>N</i>-alkyl benzamide umami flavour compounds: <i>N</i>-(heptan-4-yl)benzo[d][1,3]dioxole-5-carboxamide and (<i>R</i>)-<i>N</i>-(1-methoxy-4-methylpentan-2-yl)-3,4-dimethylbenzamideDonald S Karanewsky, Amy J Arthur, Hanghui Liu, et al.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 2, 2014

Toxicological evaluation of two flavors with modifying properties: 3-((4-amino-2,2-dioxido-1H-benzo[c][1,2,6]thiadiazin-5-yl)oxy)-2,2-dimethyl-N-propylpropanamide and (S)-1-(3-(((4-amino-2,2-dioxido-1H-benzo[c][1,2,6]thiadiazin-5-yl)oxy)methyl)piperidin-1-yl)-3-methylbutan-1-oneAmy J Arthur, Donald S Karanewsky, Mike Luksic, et al.

Toxicology Reports|October 1, 2017

Toxicological evaluation of the flavour ingredient 4-amino-5-(3-(isopropylamino)-2,2-dimethyl-3-oxopropoxy)-2-methylquinoline-3-carboxylic acidAmy J Arthur, Donald S Karanewsky, Hanghui Liu, et al.

Toxicology Reports|September 30, 2017

Toxicological evaluation of two novel bitter modifying flavour compounds: 3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1<i>H</i>-pyrazol-4-yl)-1-(3-hydroxybenzyl)imidazolidine-2,4-dione and 3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1<i>H</i>-pyrazol-4-yl)-1-(3-hydroxybenzyl)-5,5-dimethylimidazolidine-2,4-dioneDonald S Karanewsky, Amy J Arthur, Hanghui Liu, et al.

Toxicology Reports|September 30, 2017

Toxicological evaluation of a novel umami flavour compound: 2-(((3-(2,3-Dimethoxyphenyl)-1<i>H</i>-1,2,4-triazol-5-yl)thio)methyl)pyridineDonald S Karanewsky, Amy J Arthur, Hanghui Liu, et al.

Bioorganic & Medicinal Chemistry Letters|February 17, 2005

Structure-activity relationships and sub-type selectivity in an oxabicyclic estrogen receptor alpha/beta agonist scaffoldLawrence G Hamann, J Hoyt Meyer, Daniel A Ruppar, et al.

Toxicology Reports|September 30, 2017

Toxicological evaluation of the flavour ingredient <i>N</i>-(1-((4-amino-2,2-dioxido-1<i>H</i>-benzo[<i>c</i>][1,2,6]thiadiazin-5-yl)oxy)-2-methylpropan-2-yl)-2,6-dimethylisonicotinamide (S2218)Donald S Karanewsky, Guy Servant, Hanghui Liu, et al.

Ejhaem|July 18, 2022

The ClpP activator ONC-212 (TR-31) inhibits BCL2 and B-cell receptor signaling in CLLNarjis Fatima, Yandong Shen, Kyle Crassini, et al.

Pageof 5